Search research articles
Contact Us
Filters
Showing results (181-190 of 201) with videos related to
Page
of 21
Sort By:
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics
|
August 28, 2012
A Turkish Gynecologic Oncology Group study of fertility-sparing treatment for early-stage endometrial cancer
Polat Dursun, Serkan Erkanli, Ahmet Bariş Güzel, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics
|
March 24, 2022
OPEC study: An international multicenter study of ovarian preservation in endometrial cancers
Utku Akgor, Ali Ayhan, Alexander Shushkevich, et al.
Current Oncology (Toronto, Ont.)
|
December 13, 2021
Could the Long-Term Oncological Safety of Laparoscopic Surgery in Low-Risk Endometrial Cancer also Be Valid for the High-Intermediate- and High-Risk Patients? A Multi-Center Turkish Gynecologic Oncology Group Study Conducted with 2745 Endometrial Cancer Cases. (TRSGO-End-001)
Mehmet Ali Vardar, Ahmet Baris Guzel, Salih Taskin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 5, 2019
SATEN III-Splitting Adjuvant Treatment of stage III ENdometrial cancers: an international, multicenter study
Ilker Kahramanoglu, Mehmet Mutlu Meydanli, Siarhei Taranenka, et al.
Gynecologic Oncology
|
September 11, 2013
Effect of surgical staging on 539 patients with borderline ovarian tumors: a Turkish Gynecologic Oncology Group study
Tevfik Guvenal, Polat Dursun, Pinar S Hasdemir, et al.
Journal of Cancer Research and Therapeutics
|
September 26, 2025
Predictors and treatment of ısolated recurrence in vulvar cancer confined to the vulva or perineum
Kemal Güngördük, Fuat Demirkiran, Ghanim Khatib, et al.
Journal of Gynecologic Oncology
|
May 26, 2017
Prognostic factors and treatment outcomes in surgically-staged non-invasive uterine clear cell carcinoma: a Turkish Gynecologic Oncology Group study
Mustafa Erkan Sarı, Mehmet Mutlu Meydanlı, Osman Türkmen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 26, 2024
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial
Christian Marth, Richard G Moore, Mariusz Bidziński, et al.
Gynecologic Oncology
|
January 27, 2023
Role of adjuvant therapy in intermediate-risk cervical cancer patients - Subanalyses of the SCCAN study
David Cibula, Huseyin Akilli, Jiri Jarkovsky, et al.
Journal of Gynecologic Oncology
|
June 29, 2017
Factors associated with survival after relapse in patients with low-risk endometrial cancer treated with surgery alone
Nazli Topfedaisi Ozkan, Mehmet Mutlu Meydanlı, Mustafa Erkan Sarı, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 201) with videos related to
Sort By:
Page
of 21
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics
|
August 28, 2012
A Turkish Gynecologic Oncology Group study of fertility-sparing treatment for early-stage endometrial cancer
Polat Dursun, Serkan Erkanli, Ahmet Bariş Güzel, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics
|
March 24, 2022
OPEC study: An international multicenter study of ovarian preservation in endometrial cancers
Utku Akgor, Ali Ayhan, Alexander Shushkevich, et al.
Current Oncology (Toronto, Ont.)
|
December 13, 2021
Could the Long-Term Oncological Safety of Laparoscopic Surgery in Low-Risk Endometrial Cancer also Be Valid for the High-Intermediate- and High-Risk Patients? A Multi-Center Turkish Gynecologic Oncology Group Study Conducted with 2745 Endometrial Cancer Cases. (TRSGO-End-001)
Mehmet Ali Vardar, Ahmet Baris Guzel, Salih Taskin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 5, 2019
SATEN III-Splitting Adjuvant Treatment of stage III ENdometrial cancers: an international, multicenter study
Ilker Kahramanoglu, Mehmet Mutlu Meydanli, Siarhei Taranenka, et al.
Gynecologic Oncology
|
September 11, 2013
Effect of surgical staging on 539 patients with borderline ovarian tumors: a Turkish Gynecologic Oncology Group study
Tevfik Guvenal, Polat Dursun, Pinar S Hasdemir, et al.
Journal of Cancer Research and Therapeutics
|
September 26, 2025
Predictors and treatment of ısolated recurrence in vulvar cancer confined to the vulva or perineum
Kemal Güngördük, Fuat Demirkiran, Ghanim Khatib, et al.
Journal of Gynecologic Oncology
|
May 26, 2017
Prognostic factors and treatment outcomes in surgically-staged non-invasive uterine clear cell carcinoma: a Turkish Gynecologic Oncology Group study
Mustafa Erkan Sarı, Mehmet Mutlu Meydanlı, Osman Türkmen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 26, 2024
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial
Christian Marth, Richard G Moore, Mariusz Bidziński, et al.
Gynecologic Oncology
|
January 27, 2023
Role of adjuvant therapy in intermediate-risk cervical cancer patients - Subanalyses of the SCCAN study
David Cibula, Huseyin Akilli, Jiri Jarkovsky, et al.
Journal of Gynecologic Oncology
|
June 29, 2017
Factors associated with survival after relapse in patients with low-risk endometrial cancer treated with surgery alone
Nazli Topfedaisi Ozkan, Mehmet Mutlu Meydanlı, Mustafa Erkan Sarı, et al.
Page
of 21